FINWIRES · TerminalLIVE
FINWIRES

最新消息：貝克頓·迪金森公司股價上漲，此前該公司公佈第二財季業績超出預期；維托·羅克被任命為財務長。

By

-- （第一段和標題更新了最新的股價走勢。） 貝克頓·迪金森公司 (BDX) 股價週四上漲 5.6%，此前該公司公佈了超出預期的第二財季業績，並任命維托·羅克 (Vitor Roque) 為首席財務官。 該公司週四公佈的第二財季調整後每股收益為 2.90 美元，高於去年同期的 2.79 美元。 FactSet 調查的分析師此前預期為 2.78 美元。 截至 3 月 31 日的季度營收為 47.1 億美元，高於去年同期的 44.8 億美元。 FactSet 調查的分析師先前預期為 46.7 億美元。 該公司將 2026 年調整後每股收益預期從先前的 12.35 美元至 12.65 美元上調至 12.52 美元至 12.72 美元。 FactSet 調查的分析師此前預期為 12.49 美元。該公司維持了先前個位數略高於10%的營收成長預期。 該公司還宣布，已正式任命臨時財務長維托·羅克(Vitor Roque)為該職位，即刻生效。 貝克頓·迪金森公司表示，羅克擁有超過25年的經驗，曾在該公司擔任高階財務和營運職務。

Price: $153.28, Change: $+8.52, Percent Change: +5.88%

Related Articles

Insider Trading

Teva Pharmaceutical Industries Insider Sold Shares Worth $384,444, According to a Recent SEC Filing

Amir Weiss, Chief Accounting Officer, on May 06, 2026, sold 10,679 shares in Teva Pharmaceutical Industries (TEVA) for $384,444. Following the Form 4 filing with the SEC, Weiss has control over a total of 20,016 ordinary shares of the company, with 20,016 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/818686/000119312526211855/xslF345X05/ownership.xml

$TEVA
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Doordash, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target by $2 to $240, based on 30x our 2027 EPS view, just below DASH's three-year average (~32x) given competitive threats from AI and Uber Eats, offset by the company's dominant market position and positive network effects. We raise our 2026 adjusted EPS view by $0.10 to $5.63 and 2027's by $0.06 to $7.99. We are encouraged by DASH's Q2 Marketplace GOV guidance (+36% Y/Y), an encouraging result following relatively soft guidance for Q1, especially given fears of a weakening consumer. International sales continue to scale solidly, with Deliveroo accelerating to 14% Y/Y growth in Q1 vs. 7% growth in Q4 (we expect continued improvement all year). Margin pressure remains (adjusted EBITDA margin -20 bps Y/Y to 2.4%) but should fade as platform integration activities finish up early next year. Adjusted EBITDA guidance (midpoint of $820M) was above expectations ($742M), despite the company expecting another $50M gas relief charge, which should persist amid the Strait of Hormuz closure.

$DASH
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Tyson Foods, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target remains $76, a 15x multiple of projected FY 27 EPS of $5.09 (raised by $0.02). We also lift our FY 26 (Sep.) EPS est. by $0.09 to $4.11. This multiple is slightly above TSN's long-term average of 14x, reflecting favorable secular tailwinds, including a continued shift in consumer preferences toward protein and improved earnings growth potential as the Beef segment recovers, likely in FY 27. Operationally, TSN is executing well, particularly in Chicken, where margins continue to widen, up 290 bps year over year in FQ2. Beef remains pressured by historically tight cattle supplies, with the U.S. herd at its lowest level since 1951, though we expect margins to improve following recent restructuring actions, including rightsizing production to improve capacity utilization. TSN's balance sheet is solid, noting its leverage ratio (net debt/adjusted EBITDA) has now improved to 2.2x vs. 3.9x two years ago. This provides a decent degree of financial flexibility in our view.

$TSN
最新消息：貝克頓·迪金森公司股價上漲，此前該公司公佈第二財季業績超出預期；維托·羅克被任命為財務長。 | FINWIRES